Nuvectis Pharma, Inc.
USD18.20
-10.33 (-36.21%)
CEO
Ron Bentsur
IPO Date
2022-02-04
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$20.83
Prev. Close
$28.53
Day Low
$18.00
Day High
$21.24
52W Low
$5.55
52W High
$29.27
Market Cap
$0.48B
Volume
2.36M
| -4.9 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -182.4% | -116.0% | 0.00 | 2.75 | -5.8 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -134.2% | -93.5% | 0.00 | 3.30 | -5.0 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | 117.1% | -193.6% | 0.00 | 2.41 | -3.2 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | 100.0% | 0.0% | 0.00 | 0.00 | -4133.3 |
| -5.6 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -31.1% | -21.0% | 0.00 | 3.07 | -4.6 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -37.5% | -23.5% | 0.00 | 2.66 | -6.3 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -25.4% | -17.7% | 0.00 | 3.28 | -9.1 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -64.3% | -33.6% | 0.00 | 2.09 | -4.2 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -37.8% | -24.0% | 0.00 | 2.74 | -6.5 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -35.3% | -24.2% | 0.00 | 3.17 | -5.9 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -29.7% | -21.2% | 0.00 | 3.46 | -7.9 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -54.3% | -34.5% | 0.00 | 2.75 | -5.5 |